Steven Singh

A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy

Guidelines for the diagnosis and treatment of chronic heart failure

Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations

N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

Ventricular Arrhythmias in Adult Aortic Stenosis

Optimizing therapy for complex or refractory heart failure: A management algorithm

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction

Wound repair and regeneration

Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials

Physiology and immunology of the cholinergic antiinflammatory pathway

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials

Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition

Comparative Efficacy of Dronedarone and Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation

Adverse Effects of Amiodarone

Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation

The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure

Management of atrial fibrillation in patients with heart failure

A Short‐Term, Randomized, Double‐Blind, Parallel‐Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study

The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

Predictors of mortality and morbidity in patients with chronic heart failure

Thyroid Hormone and the Cardiovascular System

Nonresolving Inflammation

Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias

Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction

Rate or rhythm control in persistent atrial fibrillation?

The MUSTT Study: Evaluating Testing and Treatment

2007 Guidelines for the Management of Arterial Hypertension

Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials

Regression of Electrocardiographic Left Ventricular Hypertrophy and Decreased Incidence of New-Onset Atrial Fibrillation in Patients With Hypertension

Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation

A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease

Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation

Rationale and current perspective for early rhythm control therapy in atrial fibrillation

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Statin use and development of atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials and observational studies

Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy

Effect of Carvedilol on Survival in Severe Chronic Heart Failure

Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia

Randomised trial of low-dose amiodarone in severe congestive heart failure

The Management of Chronic Heart Failure

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

The role of exercise and PGC1α in inflammation and chronic disease

Electrical Remodeling of the Human Atrium: Similar Effects in Patients With Chronic Atrial Fibrillation and Atrial Flutter

Atrial Fibrillation and Congestive Heart Failure: Risk Factors, Mechanisms, and Treatment

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

Treatment of Hypertension in Patients 80 Years of Age or Older

Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance

A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation

Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation

Electrocardiographic differentiation of atrial flutter from atrial fibrillation by physicians

Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure

Task Force on Sudden Cardiac Death of the European Society of Cardiology

Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management

Obesity Paradox and Cardiorespiratory Fitness in 12,417 Male Veterans Aged 40 to 70 Years

Dronedarone for prevention of atrial fibrillation: A dose-ranging study

Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode

Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT

Prevalence and Incidence of Arrhythmias and Sudden Death in Heart Failure

Sudden Death Due to Cardiac Arrhythmias

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

Shock Anxiety among Implantable Cardioverter Defibrillator Recipients with Recent Tachyarrhythmia

Atrial fibrillation: current knowledge and recommendations for management*1

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II

Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Antiarrhythmic Drugs for Maintaining Sinus Rhythm After Cardioversion of Atrial Fibrillation

Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter

Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure

Expansion of Heart Failure Device Therapy Into a Rural Indigent Population in Louisiana: Potential Economic and Health Policy Implications

The inflammatory reflex

Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation*

Systematic review of the management of atrial fibrillation in patients with heart failure

A non-exercise testing method for estimating cardiorespiratory fitness: associations with all-cause and cardiovascular mortality in a pooled analysis of eight population-based cohorts

Pharmacological rate control of atrial fibrillation

Atrial Fibrillation

Structural and Functional Remodeling of the Left Atrium

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Increased Mortality after Dronedarone Therapy for Severe Heart Failure

Management of atrial fibrillation in patients with heart failure

Sudden Cardiac Death Risk Stratification in Patients With Nonischemic Dilated Cardiomyopathy

Frailty in elderly people

Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers

Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation

Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure

Use of implantable cardioverter-defibrillators for primary prevention in older patients: A systematic literature review and meta-analysis

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo

Diagnosis and Management of the Metabolic Syndrome

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Amiodarone Inhibits Production of Tumor Necrosis Factor-α by Human Mononuclear Cells

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients

Chronic Heart Failure in the United States

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Recommendations for Clinical Exercise Laboratories

Review: Mortality trends in the general population: the importance of cardiorespiratory fitness

A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias

Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease

Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association

2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial

Exercise and Physical Activity

American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death

Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery

The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes

Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2)

The Importance of Cardiorespiratory Fitness in the United States: The Need for a National Registry

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality

Antiarrhythmic Drug Therapy for Atrial Fibrillation

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death

Sudden Cardiac Death

Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation

Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device

Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients

Exercise Capacity and Mortality in Older Men

Resource Use and Survival of Patients Hospitalized with Congestive Heart Failure: Differences in Care by Specialty of the Attending Physician

Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery

Acute Coronary Findings at Autopsy in Heart Failure Patients With Sudden Death

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Exercise Capacity and All-Cause Mortality in Male Veterans With Hypertension Aged ≥70 Years

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

Multicenter Automatic Defibrillator Implantation Trial II (MADIT II): Design and Clinical Protocol

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Ambulatory Ventricular Arrhythmias in Patients With Heart Failure Do Not Specifically Predict an Increased Risk of Sudden Death

The Effects of Amiodarone on the Thyroid*

Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force

Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.

Molecular Mechanisms of Myocardial Remodeling

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Asymptomatic or “Silent” Atrial Fibrillation

Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function

Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina11This document was approved by the American College of Cardiology Board of Trustees in March 1999, the American Heart Association Science Advisory and Coordinating Committee in March 1999, and the American College of Physicians-American Society of Internal Medicine Board of Regents in February 1999.When citing this document, please use the following citation format: Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O’Rourke RA, Schafer WP, Williams SV. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092–197.This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Reprints of this document are available by calling 1-800-253-4636 or writing the American College of Cardiology, Educational Services, at 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint number 71-0166. To obtain a reprint of the Executive Summary and Recommendations published in the June 1, 1999 issue of Circulation, ask for reprint number 71-0167. To purchase bulk reprints (specify version and reprint number): Up to 999 copies call 1-800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Rationale and Design of the Henry Ford ExercIse Testing Project (The FIT Project)

Atrial fibrillation: cure or treat?

Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation

Exercise capacity and heart rate recovery as predictors of coronary heart disease events, in patients with heterozygous Familial Hypercholesterolemia

Safety and Efficacy of Monotherapy with Fantofarone, a Novel Calcium Channel Antagonist, in Patients with Chronic Stable Angina Pectoris

Pulmonary Effect of Amiodarone in Patients With Heart Failure

Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])

Amiodarone versus Sotalol for Atrial Fibrillation

Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs’ Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure)

QRS duration and mortality in patients with congestive heart failure

Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia

Ventricular Arrhythmias Associated with Congestive Heart Failure: The Role for Amiodarone

Cost Effectiveness of Cardiac Resynchronization Therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial

Thyroid Function Abnormalities during Amiodarone Therapy for Persistent Atrial Fibrillation

Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: A substudy of the SAFE-T trial

The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction

Duration of effects of isradipine during twice daily therapy in angina pectoris

Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004

Intravenous Dofetilide, a Class III Antiarrhythmic Agent, for the Termination of Sustained Atrial Fibrillation or Flutter

Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy

Quality of Life and Exercise Performance in Patients in Sinus Rhythm Versus Persistent Atrial Fibrillation

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)

Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery

Antianginal and Antiischemic Efficacy of Monotherapy Extended‐Release Nisoldipine (Coat Core) in Chronic Stable Angina

Effect of Amiodarone on Clinical Status and Left Ventricular Function in Patients With Congestive Heart Failure

Exercise Capacity and Blood Pressure Associations With Left Ventricular Mass in Prehypertensive Individuals

The Role of Amiodarone After a Myocardial Infarction

Prior Coronary Artery Bypass Surgery and Risk of Death Among Patients With Ischemic Left Ventricular Dysfunction

A graded association of exercise capacity and all-cause mortality in males with high-normal blood pressure

Implantable Cardioverter Defibrillator Therapy and the Need for Concomitant Antiarrhythmic Drugs

Exercise Capacity and Mortality in Hypertensive Men With and Without Additional Risk Factors

Exercise Capacity and Mortality in Black and White Men

Spontaneous Conversion and Maintenance of Sinus Rhythm by Amiodarone in Patients With Heart Failure and Atrial Fibrillation

Spontaneous coronary artery dissection: aggressive vs. conservative therapy.

Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter

AB24-2